Executive Summary
This Material Events Monitor digest covers 50 filings, predominantly 8-Ks, revealing a market heavily engaged in strategic transactions and leadership transitions. A clear theme is the aggressive pursuit of growth through M&A, with notable deals in financial services (Equity Bancshares acquiring Lincoln Bancorp), industrial distribution (Hillman Solutions buying Kanebridge), and specialty materials (Apogee Enterprises acquiring GroGlass).
Concurrently, the SPAC market remains active but faces significant headwinds, with several entities (Andretti Acquisition Corp. II, Wintergreen Acquisition Corp.) securing short-term extensions and non-redemption agreements to avoid liquidation, highlighting a challenging environment for de-SPAC transactions. Leadership changes are widespread, with several high-profile CFO and C-suite appointments (T-Mobile, Albemarle, Passage BIO) signaling strategic pivots or succession planning. Financially, the digest shows a bifurcated market: high-growth software (Guidewire) and logistics (Radiant) companies are investing in leadership and capacity, while pre-revenue biotechs (NextCure) and distressed entities (SunPower, Faraday Future) are taking defensive actions like lease terminations and warrant cancellations to preserve capital. The overall sentiment is cautiously optimistic, with a focus on execution risk and the ability of companies to navigate integration and funding challenges.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from September 02, 2026.
Investment Signals (11)
- Equity Bancshares (EQBK) (BULLISH)▲
Acquiring Lincoln Bancorp for $123.8M in a deal projected to be EPS accretive by 5.1% in 2027 and 7.5% in 2028, with tangible book value dilution earned back in <3 years. This signals a disciplined, value-accretive consolidation strategy in regional banking
- Guidewire Software (GWRE) (BULLISH)▲
FY2026 total revenue grew 23% YoY to $1.475B and ARR grew 19% to $1.242B, with non-GAAP diluted EPS up 37% to $3.43. Despite a Q4 license revenue decline of 18%, the strong ARR growth and FY2027 guidance for ARR of $1.45-$1.46B indicate robust recurring revenue momentum
- Apogee Enterprises (APOG) (BULLISH)▲
Acquiring GroGlass for up to €62.5M, expected to contribute >$30M in revenue at ~25% adjusted EBITDA margin with $4M+ in identified cost synergies. This is a high-ROI bolt-on acquisition in a high-margin niche, funded from existing liquidity
- Faraday Future (FFIE) (BULLISH)▲
Canceled all 21M+ outstanding Incremental Warrants from its March 2025 financing, eliminating ~57.5% of potential dilution and reducing liabilities by ~$5.8M. This aggressive balance sheet cleanup is a strong signal of management's commitment to protecting existing shareholders
-
Raised $26.2M in an equity private placement anchored by John Doerr's family office at a valuation of just 0.20x sales ($60M on $300M revenue). CEO's projection of a 4x-11x ROI multiple signals a deep value turnaround play, but execution risks are extreme [BULLISH/BEARISH]
- HF Foods Group (HFFG) (BULLISH)▲
Completed its first international expansion by acquiring Searay Foods for CAD$47.9M, expected to be immediately accretive to margins and EPS. This diversifies revenue streams and provides a new growth vector into the Canadian ethnic food market
- Radiant Logistics (RLGT) (BULLISH)▲
Appointed David Buss as COO, who previously improved DB Schenker's North America operating margin by over 200% in five years. This signals a clear strategic focus on operational efficiency and margin expansion
- Netcapital (NCPLW) (BEARISH)▲
Director resigned citing an ongoing SEC civil action against the company. This is a severe governance red flag, indicating potential legal and regulatory liabilities that could impair operations and stock value
- Ribbon Acquisition Corp. (RBNC) ↓ (BEARISH)▲
Entered into highly dilutive financing agreements (SEPA for $100M, convertible note at 17.5% discount) for its SPAC merger. The terms are punitive to existing shareholders, signaling desperation for capital to close the deal
- CF Industries (CF) (NEUTRAL)▲
Vice President and CAO Richard Hoker announced retirement effective March 2027. While routine, the extended timeline (6+ months) could signal a lack of urgency or a planned, orderly transition, which is neutral but warrants monitoring for succession quality
- T-Mobile US (TMUS) ↓ (BULLISH)▲
Appointed Jessica Uhl (ex-Shell CFO) as CFO Designate, reaffirming 2026 guidance and capital return program. This is a high-quality hire from a blue-chip company, signaling strong financial stewardship continuity
Risk Flags (10)
- Andretti Acquisition Corp. II (POLE)↓ [HIGH RISK]▼
Filed multiple non-redemption agreements but explicitly stated they are 'not expected to increase the likelihood' of shareholder approval for a business combination extension. This is a strong signal that the SPAC is at high risk of failing to close a deal and liquidating
- Netcapital (NCPLW) [HIGH RISK]▼
Director resigned due to an SEC civil action filed against the company. This legal overhang creates significant uncertainty regarding fines, penalties, and potential business disruptions
- SunPower Inc. (SPWR)↓ [HIGH RISK]▼
CEO explicitly cited 'loss of the Investment Tax Credit' and 'execution issues' as reasons for the stock trading under $1. The company is in a distressed state, relying on a dilutive equity raise from a single investor to stabilize operations
- Wintergreen Acquisition Corp. (WTGUR)↓ [HIGH RISK]▼
Entered into a one-month, interest-free promissory note to extend its business combination deadline. This last-minute, short-term funding signals a desperate scramble to find a deal and a high probability of eventual liquidation
- Guidewire Software (GWRE) [MEDIUM RISK]▼
Q4 GAAP net income fell 40% YoY to $31.4M due to a $24M foreign currency loss, and license revenue declined 18% in Q4. While ARR is strong, the volatility in license revenue and FX exposure are near-term headwinds
- BCP Investment Corp (BCP)↓ [MEDIUM RISK]▼
Refinanced $10M of 5.25% notes with new 7.50% notes. While extending maturities, the 225 bps increase in interest cost on this tranche will pressure net investment income
- NextCure (NXTC) [MEDIUM RISK]▼
Terminated its lab lease, paying a $0.8M termination fee, with no new revenue or partnership announcements. This is a clear sign of a cash-burn reduction strategy, typical of a pre-revenue biotech running low on funds
- Reliance Global Group (EZRA) [MEDIUM RISK]▼
Adopted a poison pill, citing that its asset value exceeds market cap. While a defense mechanism, it can also signal that management is aware of a potential activist or hostile bidder, creating uncertainty
- Ribbon Acquisition Corp. (RBNC)↓ [HIGH RISK]▼
The financing terms are highly dilutive, including a 17.5% discount on a convertible note and a 1.75% commitment fee. This structure severely disadvantages existing shareholders and signals a weak negotiating position
- Bunge Global SA (BG)↓ [LOW RISK]▼
Controller and CAO retirement planned for March 2027. While orderly, the loss of a key financial reporting executive, even with a successor, introduces a period of transition risk during a complex global operating environment
Opportunities (10)
- Apogee Enterprises (APOG) / GroGlass Acquisition (OPPORTUNITY)◆
The deal is immediately accretive to margins (25% EBITDA) with $4M+ in identified synergies, funded from cash. This is a textbook bolt-on acquisition that should drive EPS growth without significant balance sheet strain.
- Equity Bancshares (EQBK) / Lincoln Bancorp Merger (OPPORTUNITY)◆
The deal is projected to be 5.1% accretive to 2027 EPS and 7.5% to 2028 EPS, with tangible book value dilution earned back in <3 years. This offers a clear, quantifiable path to value creation for shareholders.
- Guidewire Software (GWRE) / Recurring Revenue Growth (OPPORTUNITY)◆
With ARR growing 19% to $1.242B and FY2027 guidance of $1.45-$1.46B, the company has a strong, predictable revenue stream. The dip in license revenue is a transition to a subscription model, and the 37% growth in non-GAAP EPS shows underlying profitability.
- Faraday Future (FFIE) / Balance Sheet Cleanup (OPPORTUNITY)◆
The cancellation of all incremental warrants removes a massive overhang of potential dilution. This decisive action, combined with the reduction in liabilities, could be a catalyst for a re-rating if the company can show progress on production.
- HF Foods Group (HFFG) / Canadian Expansion (OPPORTUNITY)◆
The Searay acquisition is immediately accretive and marks a logical first step into international markets. The deal provides access to new suppliers and a new customer base in Canada, diversifying away from the US market.
- Vaxcyte (PCVX) / Key Clinical Catalyst (OPPORTUNITY)◆
The company narrowed guidance for topline Phase 3 data for VAX-31 to end of October 2026. This provides a clear, near-term binary catalyst. The hiring of high-profile executives from Pfizer and Eli Lilly adds confidence in execution capability.
- T-Mobile US (TMUS) / Strong Leadership & Guidance↓ (OPPORTUNITY)◆
The appointment of a high-caliber CFO from Shell, combined with reaffirmed 2026 guidance and a capital return program, signals stability and confidence. This is a defensive quality play in a volatile market.
- Radiant Logistics (RLGT) / Margin Expansion Potential (OPPORTUNITY)◆
The new COO has a proven track record of dramatically improving operating margins (200%+ improvement at DB Schenker). If he can replicate this success, RLGT could see significant EPS growth.
- Hillman Solutions (HLMN) / Industrial Market Expansion (OPPORTUNITY)◆
The $315M Kanebridge acquisition expands Hillman's industrial addressable market to ~$3B and adds 44,000 SKUs. This is a strategic move into a higher-growth, more diversified end-market.
- Profound Medical (PROF) / New Leadership for Commercialization (OPPORTUNITY)◆
The appointment of Richard Fabian, former CEO of FUJIFILM Sonosite, as President signals a shift from R&D to commercial execution. His experience in scaling healthcare businesses could be a catalyst for revenue growth.
Sector Themes (6)
- SPACs in Distress◆
Multiple SPAC filings (Andretti II, Wintergreen, Ribbon) reveal a market under severe pressure. They are using dilutive financing, short-term promissory notes, and non-redemption agreements that explicitly state they may not prevent liquidation. The market is signaling a high failure rate for pending de-SPAC transactions.
- Strategic M&A for Growth & Diversification◆
A clear theme is companies using M&A to expand into new geographies (HF Foods into Canada), new product categories (Hillman into industrial fasteners), or high-margin niches (Apogee into advanced glass coatings). These are not just scale plays but strategic pivots to higher-growth markets.
- Leadership Churn as a Strategic Signal◆
The digest is filled with high-profile C-suite changes. The nature of the hire provides a strong signal: T-Mobile and Profound Medical are hiring for commercial and financial maturity; Radiant Logistics is hiring for operational efficiency; Passage Bio and Vaxcyte are hiring for clinical and regulatory expertise. The market is voting with talent.
- Capital Preservation in Pre-Revenue/Loss-Making Companies◆
Companies like NextCure (lease termination), Faraday Future (warrant cancellation), and SunPower (dilutive equity raise) are all taking actions to extend their cash runway. This is a defensive theme, highlighting the precarious position of companies that cannot generate positive cash flow from operations.
- Financial Sector Consolidation◆
The Equity Bancshares/Lincoln Bancorp deal is a microcosm of a larger trend in regional banking. Smaller banks are merging to gain scale, improve efficiency, and compete with larger institutions. The projected EPS accretion and quick TBV earn-back make these deals attractive for investors.
- Governance Red Flags Triggering Action◆
The Netcapital director resignation due to an SEC lawsuit and the Reliance Global Group poison pill adoption are examples of governance events that create immediate uncertainty. Investors should scrutinize companies where board members depart under a cloud or where defensive measures are adopted without clear justification.
Watch List (8)
- Vaxcyte (PCVX)👁
Topline Phase 3 data for VAX-31 expected by end of October 2026. This is a major binary catalyst for the stock.
-
Special meeting on September 8, 2026, to vote on business combination extension. Failure to approve will likely lead to liquidation.
-
Business combination deadline extended to September 30, 2026. Monitor for any announcement of a target or further extension requests.
-
Watch for execution against the CEO's plan to grow revenue to $500M and achieve profitability. The company's ability to stabilize operations after the capital infusion is critical.
- Equity Bancshares (EQBK)👁
Merger with Lincoln Bancorp expected to close in Q4 2026. Monitor for regulatory approvals and any updates on integration progress.
-
CEO succession on February 1, 2027. Watch for any strategic shifts or changes in capital allocation under the new leadership from BHP.
- Medicus Pharma (MDCX)👁
Co-development deal with Pfizer for an ADC. Monitor for any updates on clinical trial initiation or milestone achievements that could trigger payments.
-
CFO transition in February 2027. Monitor for any changes to the capital return program or financial guidance under the new CFO.
Filing Analyses
(50)
03-09-2026
Ribbon Acquisition Corp. entered into a series of financing agreements with Meteora Select Trading Opportunities Master, LP in connection with its pending business combination with DRC Medicine Ltd. The agreements include a Forward Purchase Agreement for up to 4,100,000 shares, a Standby Equity Purchase Agreement (SEPA) for up to $100,000,000, and a $1,212,121 convertible promissory note (issued at a 17.5% discount). While the financing provides substantial liquidity for the merger, the terms are highly dilutive to existing shareholders, with the Investor receiving a 1.75% commitment fee ($1,750,000), a 7% payment premium on the note, and conversion prices as low as 95% of the lowest VWAP over five days.
- · The Forward Purchase Agreement allows the Investor to purchase up to 4,100,000 shares of PubCo common stock at the per-share redemption price.
- · The per-share reference price resets weekly after the first 30 days to the lower of $10.00 and the prior week's VWAP.
- · The SEPA has no minimum usage requirement and no fee on unused commitment.
- · The Note bears no interest absent an event of default, at which point it accrues at 18% per annum.
- · Upon closing, certain PubCo shareholders will deposit 9.9% of outstanding Common Shares into escrow.
- · The Investor has a right of first refusal on up to 33% of future financings for six months after the valuation date.
- · The Note requires 33% of net proceeds from most financings to be applied to repayment of outstanding principal.
03-09-2026
Crown PropTech Acquisitions (CPTKW) has entered into an amended and restated business combination agreement with Mkango Rare Earths Limited and its subsidiaries, dated September 2, 2026. The transaction involves a merger where Mkango (Cayman) Limited will merge into Crown PropTech, with Mkango BVI becoming the public company (PubCo). The deal includes a pre-closing reorganization, share adjustments, and various covenants related to mining licenses, debt-to-equity exchanges, and offtake arrangements. No financial figures or period-over-period comparisons are provided in this filing.
- · The agreement amends and restates a prior business combination agreement (Original Agreement).
- · Mkango BVI will become PubCo after closing.
- · The transaction includes a Shareholder Support Agreement and Sponsor Support Agreement.
- · Conditions include a Minimum Cash Condition and regulatory approvals.
- · The agreement includes provisions for a PubCo Incentive Plan and D&O indemnification.
- · OTC Markets quotation is referenced for SPAC securities.
- · The filing does not disclose the equity value or any financial terms of the transaction.
03-09-2026
Radiant Logistics appointed David Buss as Senior Vice President and COO, effective August 31, 2026. Mr. Buss brings over 30 years of logistics experience, including a prior role as CEO of DB Schenker's North America Cluster where he improved operating margin by over 200% in five years. The company also announced its 2026 Annual Meeting will be held on November 16, 2026, with record and proposal deadlines in September.
- · Mr. Buss served as an independent private equity transportation logistics advisor from August 2025 to July 2026.
- · He was promoted to the North America Cluster leadership role at DB Schenker in April 2023 and served on the integration steering committee for the USA Truck acquisition until July 2025.
- · The employment agreement provides six months severance for termination due to death/disability or without cause, and twelve months severance if termination occurs within nine months after a Change of Control.
- · Stockholder proposals for the 2026 Annual Meeting must be received by September 27, 2026; director nominations by September 17, 2026.
- · The record date for voting at the Annual Meeting is September 29, 2026.
03-09-2026
PlusAI, a developer of AI-based virtual driver software for autonomous trucks, will go public via a merger with SPAC Texas Ventures Acquisition III Corp at an $800 million pre-money valuation. The deal brings up to ~$300 million in capital ($60M+ committed financing plus ~$236M trust) to fund commercialization. PlusAI has generated $25M in revenue to date and targets $40-50M in contracted revenue for 2026, but remains pre-commercial for its core SuperDrive product, with a targeted 2027 launch.
- · PlusAI is actively operating autonomous freight routes in Texas with Ryder and International.
- · The transaction has been unanimously approved by the boards of both companies and is expected to close in 2026.
- · Existing PlusAI stockholders, the Texas Ventures III sponsor and insiders will be subject to lock-up agreements post-closing.
- · The combined company will continue to operate as PlusAI after closing.
- · PlusAI was named one of Fast Company's World's Most Innovative Companies.
- · The SPAC is a Cayman Islands entity and may pursue an acquisition in any business or geography.
03-09-2026
Passage Bio, Inc. (PASG) has entered into an amended and restated merger agreement to acquire Remix Therapeutics, Inc. through a two-step merger process, with Remix ultimately becoming a wholly owned subsidiary of Passage. The transaction is supported by stockholder support agreements and lock-up agreements from key stakeholders in both companies, and includes a concurrent financing via a subscription agreement. The deal is subject to stockholder approvals and regulatory conditions.
- · The merger agreement was originally dated June 24, 2026 and amended and restated on September 2, 2026.
- · The transaction involves a first merger of Peregrine Merger Sub, Inc. with and into Remix, followed by a second merger of Remix into Peregrine Merger Sub II, LLC.
- · Stockholder support agreements and lock-up agreements were executed concurrently with the amended agreement.
- · A concurrent financing is being conducted through an Amended and Restated Subscription Agreement for the purchase of Remix Common Stock and/or pre-funded warrants.
03-09-2026
Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors on September 1-2, 2026, to secure commitments not to redeem up to 2,200,000 public shares in exchange for up to 550,000 Pubco shares (if a business combination closes by June 9, 2027) or up to an additional 183,334 Pubco shares (if closed after that date). These agreements, combined with prior agreements covering up to 3,600,000 non-redeemed shares, aim to increase trust account funds ahead of the September 8, 2026 special meeting to extend the business combination deadline to September 9, 2027. However, the filing notes the agreements are not expected to increase the likelihood of shareholder approval for the extension, and the company faces ongoing risks including potential failure to consummate a business combination.
- · The special meeting was originally convened on August 28, 2026, then adjourned to September 8, 2026 at 10:00 a.m. Eastern Time.
- · The non-redemption agreements terminate upon the earliest of: failure to approve extension, company determination not to proceed, fulfillment of obligations, liquidation/dissolution, mutual written agreement, or if the investor exercises redemption rights and shares are actually redeemed.
- · The company is a blank check (SPAC) company incorporated in the Cayman Islands, with securities traded on Nasdaq under symbols POLEU, POLE, and POLEW.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
03-09-2026
Apogee Enterprises announced the acquisition of GroGlass, a European provider of high-performance glass surface solutions, for up to €62.5 million (~$72.5 million) on a cash-free, debt-free basis. The acquisition is expected to contribute over $30 million in revenue at approximately 25% adjusted EBITDA margin in the first 12 months, with at least $4 million in annualized cost synergies identified. The transaction is expected to close in fiscal Q3 2027 and will be integrated into Apogee's Performance Surfaces Segment.
- · GroGlass is located in Riga, Latvia, and specializes in anti-reflective and other advanced coatings for display, architectural, and technical applications.
- · The acquisition will be financed using cash on hand and the Company’s existing credit facility.
- · The purchase price includes up to €10 million payable over 3 years dependent on GroGlass achieving certain financial targets.
- · The transaction is subject to customary closing conditions and expected to close during fiscal 2027 third quarter.
- · Apogee plans to integrate Groglass into its Performance Surfaces Segment.
03-09-2026
Byrna Technologies appointed Matthew McBrady, Ph.D., a former long-time board member of Axon Enterprise (market cap >$50B), to its Board of Directors, increasing board size from seven to eight as part of a planned refreshment strategy. Dr. McBrady brings deep experience from Axon's growth journey, capital markets expertise as a former hedge fund and private equity investor, and currently serves as CFO of GoBrands (GoPuff). The appointment is expected to provide valuable insights for Byrna's next growth phase, though no specific financial metrics or performance data were disclosed in this filing.
- · Dr. McBrady served on Axon's board from 2001 to 2014 and again from 2016 to 2026, chairing Audit, Compensation, and M&A & Capital Structure Committees.
- · He currently serves as CFO of GoBrands (GoPuff) since 2025 and previously spent five years as Professor of Practice in Finance at Darden School.
- · Earlier career includes roles as Managing Director and CIO of Multi-Strategy Hedge Funds at BlackRock, and Senior Associate at Bain Capital.
- · He served as an international economist for President Clinton's Council of Economic Advisers and the U.S. Treasury from 1998 to 2000.
- · Dr. McBrady holds a B.A. in Economics from Harvard, an M.Sc. from Oxford (Marshall Scholar), and a Ph.D. in Business Economics from Harvard.
03-09-2026
Profound Medical Corp. appointed Richard Fabian as President, effective immediately, succeeding Mathieu Burtnyk who becomes Chief Technology Officer. Fabian brings over 29 years of healthcare industry experience, most recently as CEO of FUJIFILM Sonosite, and previously in senior roles at Philips Healthcare. The leadership change aims to sharpen execution while retaining Burtnyk to lead clinical innovation.
- · Richard Fabian holds a Bachelor of Economics from the University of Michigan and an MBA from the University of Pittsburgh Joseph M. Katz Graduate School of Business.
- · Mathieu Burtnyk is the inventor of the patented closed-loop temperature feedback control algorithm used by TULSA-PRO®.
- · Profound Medical's technologies are approved across major global markets including FDA clearance for TULSA-PRO in the US and Sonalleve HDE for osteoid osteomas.
03-09-2026
Hillman Solutions Corp. completed its acquisition of Kanebridge, LLC for approximately $315 million, funded through cash, a draw on its asset-based credit facility, and a new $200 million term loan B at SOFR plus 200 bps. The deal adds over 44,000 industrial fastener SKUs and expands Hillman's industrial addressable market to about $3 billion, marking its first U.S. master distribution platform in the industrial fastener market. While the acquisition is strategically positioned to benefit from secular tailwinds and diversify the customer base, it carries integration risks and the company faces ongoing headwinds from inflation, supply chain costs, and customer concentration.
- · Acquisition was first announced on August 3, 2026.
- · Kanebridge has been a master distributor for more than 50 years with warehouses in Illinois and California offering same-day shipment.
- · Hillman was founded in 1964 and has over 60 years of history.
- · The company filed an 8-K with Items 1.01, 2.01, 8.01, and 9.01.
03-09-2026
Fortress Credit Realty Income Trust, through its special purpose vehicle FCR 2026-FL1 Issuer LLC, entered into a secured note indenture on August 28, 2026, establishing a collateralized financing structure backed by commercial real estate loan interests. The indenture provides for multiple classes of notes secured by the collateral and appoints Wilmington Trust as trustee, Computershare as note administrator/custodian, and FCR CRE Holdco LLC as advancing agent. This is a standard securitization transaction that increases the company's secured debt while pledging specific asset pools.
- · The indenture authorizes the issuance of multiple classes of secured notes: Offered Notes, Income Notes, and potentially subordinate classes (Class F, Class G).
- · Collateral includes closing date collateral interests, servicing accounts, indenture accounts, eligible investments, and rights under collateral management and servicing agreements.
- · Income Note holders are explicitly not secured parties under the granting clauses, meaning they have a subordinated claim.
- · The transaction includes provisions for a clean-up call, tax redemption, optional redemption, and auction call redemption (Section 9.1).
- · The indenture allows for reinvestment of collateral and future acquisitions under specified conditions (Article 12).
- · The trustee has full secured party remedies upon an event of default, including sale of collateral.
03-09-2026
CF Industries Holdings, Inc. disclosed that Vice President, Corporate Controller, and Chief Accounting Officer Richard A. Hoker intends to retire effective March 3, 2027. The filing provides no financial data or performance metrics, only a routine officer departure announcement.
03-09-2026
IDEX Corporation entered into a Second Amended & Restated Credit Agreement dated September 3, 2026, establishing an $800,000,000 revolving credit facility with a syndicate of lenders led by Bank of America, N.A. as Administrative Agent. The agreement replaces the prior Amended and Restated Credit Agreement dated November 1, 2022, and includes certain subsidiaries as designated borrowers. The facility provides IDEX with increased liquidity and flexibility for general corporate purposes, including acquisitions and working capital.
- · The agreement includes a revolving credit facility with an aggregate commitment of $800,000,000.
- · The facility is available in U.S. Dollars and multiple alternative currencies (Euro, Sterling, Yen, Swiss Francs, Canadian Dollars, and others).
- · The agreement amends and restates the prior Amended and Restated Credit Agreement dated November 1, 2022.
- · Designated borrowers include Fast & Fluid Management B.V., IDEX International B.V., IDEX UK Ltd., IDEX Europe GmbH, and Lukas Hydraulik GmbH.
- · The facility includes a swing line loan subfacility and letter of credit subfacility.
- · The agreement contains customary representations, warranties, affirmative and negative covenants, and events of default.
- · The financial covenant is set forth in Section 7.15 of the agreement.
03-09-2026
The Scotts Miracle-Gro Company announced the departure of Christopher J. Hagedorn, Executive Vice President & Chief Strategy Officer, effective September 30, 2026. The separation was mutually agreed upon on August 29, 2026. No financial details or replacement plans were disclosed.
- · Departure effective date: September 30, 2026
- · Agreement date: August 29, 2026
- · No successor or interim arrangement mentioned
03-09-2026
Guidewire Software reported strong fiscal year 2026 results with total revenue up 23% to $1,475.4M and ARR growing 19% to $1,242M. However, license revenue declined 7% for the full year and 18% in Q4, while GAAP net income in Q4 fell to $31.4M from $52.0M a year ago due to a $24.0M foreign currency loss. The company provided fiscal 2027 guidance for ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.
- · GAAP diluted net income per share for FY 2026 was $1.63, up from $0.81 in FY 2025.
- · Non-GAAP diluted net income per share for FY 2026 was $3.43, up from $2.51 in FY 2025.
- · Cash, cash equivalents, and investments decreased to $1,215.3M from $1,483.2M at year-end FY 2025, partly due to $606.3M in share repurchases.
- · The company repurchased 4,085,350 shares at an average price of $148.41 during FY 2026.
- · GAAP net income in Q4 FY 2026 was negatively impacted by a $24.0M foreign currency loss, compared to a $2.8M gain in Q4 FY 2025.
- · Fiscal year 2027 guidance includes ending ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.
- · The company has over 570 insurers in 44 countries and has completed 1700+ implementation projects.
03-09-2026
BCP Investment Corp (formerly Portman Ridge Finance) issued $10.0 million of 7.50% notes due 2029 under its existing indenture, with proceeds used to repay $10.0 million of its 5.250% notes due 2026 (LRFC Notes). The transaction closed on September 3, 2026, and the company will issue a redemption notice for the LRFC Notes within 10 days. This refinancing extends debt maturities but increases the interest rate on the refinanced amount.
- · The new notes are issued as 'Additional Notes' under the existing indenture and will be treated as a single series with the existing 7.50% notes due 2029.
- · The offering was made under an effective Form N-2 registration statement (File No. 333-283443) declared effective on February 10, 2025.
- · The company will issue a redemption notice for at least $10.0 million of the LRFC Notes within 10 days after closing.
- · The notes are issued in global form through DTC, with Cede & Co. as nominee.
- · The company engaged Lucid Capital Markets as financial advisor for the offering.
03-09-2026
NETSTREIT Corp. announced the mutual departure of Sofia Chernylo as Senior Vice President and Chief Accounting Officer, effective September 1, 2026, with no disagreement over accounting matters. Matthew Fennewald, age 36, was appointed as her successor, bringing internal experience as Vice President, Corporate Controller since February 2024 and prior roles at PricewaterhouseCoopers and Crowe Horwath. The transition appears orderly and routine, with no new material plans or arrangements disclosed.
- · Matthew Fennewald joined NETSTREIT in August 2020 and has served as Vice President, Corporate Controller since February 2024.
- · Prior roles at NETSTREIT include Director, Corporate Controller (March 2023–February 2024), Corporate Controller (March 2022–February 2023), and Financial Reporting Manager (August 2020–February 2022).
- · Before NETSTREIT, Fennewald worked at PricewaterhouseCoopers LLP (2015–2020) and Crowe Horwath LLP (2012–2015).
- · Fennewald holds a Master of Science in Auditing and Financial Accounting from the University of North Texas and is a licensed CPA.
- · No family relationships or reportable transactions exist between Fennewald and the company's directors or executive officers.
03-09-2026
Resources Connection, Inc. (RGP) announced the resignation of CFO Jennifer Y. Ryu, effective October 2, 2026, and the appointment of Jessica Block as interim CFO. Ms. Block, who joined RGP in March 2026 as Chief AI Officer, brings over 20 years of experience in professional services, including a prior interim CFO role at Factor. The company will initiate a search for a permanent successor, while Ms. Block's appointment aims to ensure continuity and continued focus on strategic priorities, including advancing RGP's AI strategy.
- · RGP has served 90% of the Fortune 100 as of May 2026.
- · RGP has been recognized by U.S. News & World Report (2025-2026 Best Companies to Work for) and Forbes (America’s Best Midsize Employers 2026, America’s Best Management Consulting Firms 2025, World’s Best Management Consulting Firms 2025).
- · RGP is listed on the Nasdaq Global Select Market, the exchange’s highest tier by listing standards.
03-09-2026
On September 3, 2026, James River Group Holdings, Inc. (JRVR) disclosed in an 8-K filing that director Thomas L. Brown will not seek re-election at the 2026 annual general meeting, effective August 31, 2026. The departure is not due to any disagreement with the company's operations, policies, or practices. The filing does not include any financial data or forward-looking guidance.
- · Mr. Brown's decision was not due to any disagreement with the company.
- · The departure relates to the 2026 annual general meeting of shareholders.
03-09-2026
BCB Bancorp Inc. dismissed Wolf & Company, P.C. as its independent auditor and engaged Deloitte & Touche LLP as its new auditor, effective September 2, 2026. The change was approved by the Audit Committee, and there were no disagreements or reportable events with the former auditor during the past two fiscal years or the subsequent interim period. The filing does not contain any financial results or period-over-period comparisons.
- · No disagreements or reportable events occurred with Wolf & Co. during fiscal years 2024 and 2025 or the interim period through September 2, 2026.
- · Wolf & Co.'s audit reports for fiscal years 2024 and 2025 were unqualified—no adverse opinion, disclaimer, or modification.
- · Deloitte will begin with the audit of the year ending December 31, 2026, and the review of the quarter ending September 30, 2026, subject to customary client acceptance.
- · The company did not consult Deloitte on any accounting principles, transactions, or audit opinions prior to engagement.
03-09-2026
Bunge Global SA announced the planned retirement of Controller and CAO Matt Simmons effective March 31, 2027, with Richard James succeeding him on April 1, 2027. The transition is orderly and not due to any disagreement. Mr. James brings over 14 years of experience at Bunge and multiple professional certifications.
- · Matt Simmons will retire as Controller and CAO effective March 31, 2027, and will remain through the transition period.
- · Richard James, age 45, has served as Vice President, Finance Integration and Transformation since December 2022.
- · Richard James holds a Bachelor of Science in Biology from the University of London (2002) and an MBA from Columbia Business School (2012).
- · Richard James is a CPA, Chartered Professional Accountant (Canada), Chartered Accountant (England & Wales), and Certified Internal Auditor.
03-09-2026
Vaxcyte appointed Luis Jodar, Ph.D. as Chief Medical Officer and David McAvoy, J.D. as Chief Legal Officer, strengthening its leadership ahead of a key clinical milestone. The company also narrowed its guidance for topline data from the VAX-31 adult Phase 3 OPUS-1 trial to end of October 2026, from the prior Q4 2026 range. The appointments and data timeline signal progress toward a planned BLA submission and potential commercialization, though the company remains a clinical-stage entity with no approved products.
- · Luis Jodar spent 17 years at Pfizer, most recently as SVP and CMO for Vaccines and Infectious Diseases, and led clinical/regulatory work for Prevnar 13 and Prevnar 20.
- · David McAvoy spent 27 years at Eli Lilly in senior legal roles and was General Counsel of Endocyte through its $2.1B acquisition by Novartis.
- · The OPUS program includes three fully enrolled trials with 6,191 adults dosed total; ~3,500 received VAX-31.
- · OPUS-2 and OPUS-3 topline data expected in first half of 2027.
- · VAX-31 is the broadest-spectrum PCV candidate in the clinic today (31-valent).
- · VAX-24 has positive Phase 2 results in adults and infants.
- · VAX-A1 (Group A Strep) is in Phase 1.
- · VAX-GI (Shigella) is in pipeline.
- · XpressCF platform is exclusively licensed from Sutro Biopharma.
03-09-2026
Ralph Lauren Corporation announced expanded roles for key enterprise leaders effective November 29, 2026, following the retirement of COO Bob Ranftl. Halide Alagöz becomes Chief Operating & Product Officer, adding AI strategy and architecture & design to her product and merchandising responsibilities; CFO Justin Picicci adds real estate and logistics; CMO Iris Langlois-Meurinne adds licensing; and Katie Ioanilli adds the Design with Intent initiative. The changes support the Next Great Chapter: Drive strategy, but no financial metrics or performance data were disclosed.
- · Halide Alagöz will assume leadership of AI strategy and architecture & design organization.
- · Justin Picicci will add global responsibility for real estate and logistics.
- · Iris Langlois-Meurinne will take on leadership of Ralph Lauren’s licensing business.
- · Katie Ioanilli will expand her role to include Design with Intent, an industry-leading cultural collaboration initiative.
- · Bob Ranftl's retirement is effective November 29, 2026.
03-09-2026
BNB Plus Corp. announced the resignation of three directors (Robert B. Catell, Joseph D. Ceccoli, Dr. Yacov Shamash) effective September 3, 2026, with no disagreement cited, and appointed three new directors (Richard Shorten, Todd Larsen, Lok Lee) to fill the vacancies. The new directors bring ties to blockchain/AI infrastructure and a strategic advisory engagement with GlobalStake, which is affiliated with a major shareholder (Comstock). The company has paid a $300,000 pre-paid advisory fee for a four-month strategic review, and recent private placements with Comstock GP generated gross proceeds of $5.0 million and $747.8 thousand.
- · New directors Larsen and Lee will serve on Audit and Compensation Committees; Larsen also on Nominating Committee.
- · Compensation for new directors to be agreed upon at a later date.
- · GlobalStake strategic review will cover business, assets, and capital structure over an initial four-month term.
- · Comstock GP is a current shareholder and participant in both the October 2025 PIPE and May 2026 private placement.
- · No disagreements were cited for the resignations.
03-09-2026
T-Mobile US announced the planned retirement of CFO Peter Osvaldik in July 2027 and the appointment of Jessica Uhl as CFO Designate, effective mid-September 2026, to succeed him in February 2027. Uhl brings extensive financial leadership from Shell and GE Vernova. The company reaffirmed its 2026 financial guidance and capital return program.
- · Peter Osvaldik joined T-Mobile in 2016 and has served as CFO since 2020.
- · Osvaldik's one-year contract extension was previously made to support the CEO transition.
- · Jessica Uhl has a 30-year career, was CFO of Shell, and most recently President of GE Vernova.
- · The transition includes an extended transition period and a Strategic Advisor role for Osvaldik until his planned retirement on July 1, 2027.
03-09-2026
Herc Holdings Inc. entered into a Ninth Amendment to its receivables financing agreement on August 31, 2026, which increases borrowing commitments and extends the maturity date to August 31, 2027. The amendment provides greater borrowing availability for the company's special purpose vehicle, Herc Receivables U.S. LLC.
- · The Ninth Amendment increases commitments and uncommitted allocations under the RFA.
- · The maturity date of the RFA is extended to August 31, 2027.
- · The original RFA was entered into on September 17, 2018.
- · The RFA has been amended annually since 2020.
03-09-2026
NextCure, Inc. entered into a Ninth Amendment to its lease on August 28, 2026, to vacate and surrender its laboratory and office space at 8000 Virginia Manor Road, Beltsville, Maryland, effective August 31, 2026. The lease was terminated September 1, 2026, with no further rent obligations. The company paid a one-time termination fee of approximately $0.8 million and forfeited a security deposit of about $39,000, reflecting ongoing cost-reduction efforts. No new revenue or growth drivers were announced, and the company continues to operate from its Baltimore headquarters.
- · Lease originally dated January 30, 2019, was amended for the ninth time.
- · Company vacated premises on August 31, 2026, and lease termination effective September 1, 2026.
- · No new revenue, product developments, or partnerships were announced.
03-09-2026
Faraday Future entered into Incremental Warrant Termination Agreements with investors from its March 2025 financing, canceling all 21,021,369 outstanding Incremental Warrants. This action permanently removes potential dilution from their future exercise and, combined with a prior amendment, eliminates approximately 57.48% of the potential dilution from the March 2025 Financing on a fully diluted basis. The company expects these actions to directly reduce approximately $5.794 million in fair-value-measured liabilities, improving its balance sheet and capital structure.
- · The cancellation applies to all 21,021,369 Incremental Warrants issued in the 1st to 3rd closings of the March 2025 Financing.
- · An amendment dated August 20, 2026, eliminated the company's obligation to issue common warrants and incremental warrants at future closings.
- · All common warrants and Incremental Warrants under the March 2025 SPA have now been fully cancelled.
- · The reduction in liabilities is expected to directly impact the $5.794 million in fair-value-measured liabilities disclosed in the company's Q2 2026 financial results.
03-09-2026
XMax Inc. entered into Securities Purchase Agreements on August 28, 2026, to sell 352,200 shares of common stock at $8.417 per share in a private placement, raising approximately $2.96 million from non-U.S. investors under Regulation S. The shares are subject to an 18-month lock-up period, and shareholder approval was obtained on July 24, 2026, to comply with Nasdaq Listing Rule 5635(d).
- · The private placement was exempt from registration under Regulation S of the Securities Act of 1933.
- · Shareholder approval for the sale was obtained at a special meeting on July 24, 2026.
- · The lock-up period prohibits purchasers from transferring shares for 18 months from August 28, 2026.
03-09-2026
ESS Tech, Inc. entered into employment agreements with CFO Kate Suhadolnik and CSO/GC Kelly F. Goodman on August 28, 2026, formalizing terms without any change in roles or responsibilities. Each executive receives a base salary of $380,000 and enhanced severance benefits tied to a change-in-control protective period, including 12 months' salary, COBRA premiums, and full equity acceleration. The agreements also include customary non-compete and non-solicitation covenants.
- · Employment agreements were not entered into in connection with any change in title, role, or responsibilities.
- · Annual cash incentive bonus eligibility terms remain unchanged from prior disclosures.
- · Severance benefits apply only during the CIC Protective Period (one month before to 12 months after a Change in Control).
- · Severance includes 12 months' base salary, 12 months of COBRA premiums, and full acceleration of unvested equity awards.
- · Agreements contain customary confidentiality, non-solicitation, and non-competition covenants.
03-09-2026
Frontdoor, Inc. announced the resignation of Sally J. Shanks, Vice President, Chief Accounting Officer and Controller, effective September 18, 2026, to pursue other business opportunities. Her departure is not due to any disagreement with the company. CFO Jason L. Bailey will assume principal accounting officer duties until a successor is appointed.
- · Resignation effective date: September 18, 2026
- · No disagreement with company, management, or board cited
- · CFO Jason L. Bailey will serve as interim principal accounting officer
03-09-2026
SunPower Inc. raised $26.2 million in an equity private placement, with the majority funded by Sand Hill Road venture investors, led by Foris Markets (the family office of John Doerr). CEO T.J. Rodgers noted the company's share price is under $1 due to the loss of the Investment Tax Credit and execution issues in its SunPower Direct Division, but emphasized a potential 4x to 11x ROI multiple and plans to grow revenue to $500 million next year with profitability. The filing signals a critical capital infusion to stabilize operations amid market headwinds and internal misexecution.
- · Equity round anchored by Foris Markets, the family office of John Doerr.
- · Revenue is $300M but company valued at $60M (0.20x sales).
- · CEO projects a 4x to 11x ROI multiple based on four scenarios.
- · SunPower Direct Division misexecution assigned to Kapil Rai for turnaround.
- · Industry growth forecast: from 6% penetration now to 30% by 2030 per EIA, not including AI-driven electricity price increases.
03-09-2026
Wintergreen Acquisition Corp. (WTGUR) entered into an unsecured promissory note for $184,635 with MACRO DREAM Holdings Limited to fund a one-month extension of its business combination deadline from August 30, 2026, to September 30, 2026. The note bears no interest and is convertible into units at $10.00 per unit upon a business combination, but is fully forgiven if no deal closes and the company liquidates. This extension loan signals the company is still pursuing a merger but faces a tight deadline with no guarantee of completion.
- · The note is unsecured and bears no interest.
- · Proceeds must be deposited into the trust account to fund the extension.
- · Conversion is at Payee's option, limited to $1,500,000 aggregate for similar loans.
- · If no business combination occurs by September 30, 2026, the note is forgiven and Payee has no claim on trust account.
- · The same individual, Yongfang Yao, signed for both Maker and Payee, indicating a related-party transaction.
03-09-2026
Net Power Inc. closed the acquisition of EMPower's contractual rights under an EPC agreement for a 123 MW reciprocating-engine natural gas power generation facility, advancing its Project Permian in West Texas. The transaction, announced on August 24 and closed on August 31, 2026, brings Net Power's total potential capacity for the first phase to nearly 200 MW. Saulsbury remains the EPC contractor, and Wärtsilä will supply ten engine-generator sets.
- · The acquired EPC agreement includes rights and benefits under the related equipment-supply agreement for the ten engine-generator sets.
- · The facility is designed for fast-start operation and can ramp output up and down to follow variable load.
- · The ten-unit modular configuration allows individual engines to be serviced without taking the full facility offline.
- · Saulsbury will serve as turnkey EPC contractor for engineering, procurement, construction, commissioning, and start-up.
- · The transaction closed 18 days after the initial announcement.
03-09-2026
UiPath reported Q2 FY2027 revenue of $410 million, up 13% YoY, and ARR of $1.938 billion, up 12% YoY, with GAAP operating income of $32 million and non-GAAP operating income of $89 million. The company announced leadership changes, including a new CFO and a new Board member, and provided Q3 and full-year guidance. However, net new ARR of $37 million was modest, and the dollar-based net retention rate of 109% indicates slowing expansion.
- · Net new ARR of $37 million in Q2 FY2027.
- · Dollar-based net retention rate of 109%.
- · GAAP gross margin of 80% and non-GAAP gross margin of 82%.
- · Leadership changes: Ashim Gupta to focus solely on COO role; Hitesh Ramani promoted to CFO; Brad Brubaker named Chief Legal & Administrative Officer.
- · Yazdi Bagli appointed to the Board of Directors.
- · Q3 FY2027 guidance: revenue $440M-$445M, ARR $1.992B-$1.997B, non-GAAP operating income ~$100M.
- · Full year FY2027 guidance: revenue $1.789B-$1.794B, ARR $2.065B-$2.070B, non-GAAP operating income ~$445M.
- · Cash position of $1.405 billion as of July 31, 2026.
03-09-2026
Smart Sand, Inc. entered into Amendment No. 2 to its Credit Agreement on September 1, 2026, increasing the Total Revolving Credit Commitment and extending the Revolving Credit Maturity Date. The amendment required a $150,000 amendment fee and evidence of at least $20 million in Excess Availability post-closing. All existing guarantees, liens, and security interests remain in full force and effect.
- · Amendment No. 2 increases the Total Revolving Credit Commitment and extends the Revolving Credit Maturity Date.
- · Conditions precedent included updated collateral field examination and Inventory Appraisal.
- · All Loan Parties reaffirmed their guarantees, pledges, and security interests under the Loan Documents.
- · The amendment fee of $150,000 is fully earned, nonrefundable, and due on the date hereof.
03-09-2026
Bally's Corporation announced the resignation of EVP and CFO Mira Mircheva for personal reasons, effective September 4, 2026, with a transition period through September 30, 2026. The Board appointed President and Board member George Papanier as Interim CFO, effective September 4, 2026, leveraging his 40+ years of gaming industry experience and prior CFO role in 2023. The company has commenced a search for a permanent CFO, and management expressed confidence in continued operational and financial stability.
- · Mira Mircheva's resignation is effective September 4, 2026, with a transition period through September 30, 2026.
- · George Papanier previously served as interim CFO in 2023 and as CEO from February 2011 to October 2021.
- · Bally's operates 20 casinos across 11 U.S. states and one in Newcastle, UK, with approximately 17,700 slot machines, 630 table games, and 3,950 hotel rooms.
- · Bally's has over 12,000 employees globally and holds a majority interest in Bally's Intralot S.A.
03-09-2026
Reliance Global Group, Inc. (Nasdaq: EZRA) adopted a one-year stockholder rights plan (poison pill) effective September 3, 2026, to protect stockholder value from coercive takeover attempts. The plan triggers if a person or group acquires 15% or more of common stock without board approval (20% for passive institutional investors), and expires on September 3, 2027. The board believes the company's asset value exceeds its current market capitalization, but the filing does not provide any financial metrics or period-over-period comparisons.
- · Rights become exercisable at 15% ownership threshold (20% for passive institutional investors).
- · Each right entitles holder to purchase one one-thousandth of a Series A Preferred Share at $14.00.
- · Plan includes a 'qualifying offer' provision allowing stockholders to call a special meeting to vote on redeeming rights in response to a fully financed, all-cash or all-stock offer.
- · Board may exchange each outstanding right (excluding acquirer's void rights) for one share of common stock after a triggering event.
- · Plan expires on September 3, 2027, unless redeemed or terminated earlier.
03-09-2026
GrabAGun Digital Holdings Inc. (PEW-WT) announced the departure of CFO Justin Hilty, effective September 1, 2026, under a Separation Agreement. The agreement includes a six-month advisory period (minimum 40 hours/month) with an hourly cash fee, acceleration of 66,667 unvested RSUs, and standard restrictive covenants. No financial terms of the consulting fee or any severance payment were disclosed.
- · Mr. Hilty resigned as CFO effective August 14, 2026, and retired effective September 1, 2026.
- · Advisory period runs from September 1, 2026 through March 1, 2027.
- · Mr. Hilty remains subject to restrictive covenants from a Non-Competition and Non-Solicitation Agreement dated January 6, 2025.
- · The Separation Agreement includes a general release of claims through the Separation Date.
03-09-2026
Netcapital Inc. (NCPLW) disclosed the resignation of director Avi Liss on August 27, 2026, citing the SEC civil action filed against the company and certain individuals. The board elected Cesar Herrera as a new independent director on August 30, 2026, filling the vacancy and appointing him to the Audit and Compensation Committees. The filing reflects a board shake-up amid an SEC lawsuit, but no financial metrics or performance data are provided.
- · The SEC civil action was filed on August 10, 2026, in the U.S. District Court for the District of Massachusetts (Case No. 1:26-cv-13665).
- · Mr. Liss stated he did not know of, be involved in, participate in, or receive any financial benefit from the alleged conduct.
- · Cesar Herrera has served as CEO and director of KRTL Holding Group Inc. since December 2021 and holds a California real estate broker license since 2006.
- · The board determined all three directors are independent under Nasdaq rules.
- · Mr. Herrera was not designated as an audit committee financial expert.
03-09-2026
LiveWire Group, Inc. announced the resignation of Paul Krause from its Board of Directors effective August 31, 2026, and the appointment of Matt Ryan to the Board effective September 1, 2026. Mr. Ryan, who serves as Chief Marketing and Technology Officer of Harley-Davidson, Inc., will not receive additional compensation for his director role.
- · Paul Krause resigned effective end of day August 31, 2026.
- · Matt Ryan was appointed effective September 1, 2026.
- · Mr. Ryan will not receive additional compensation for his board service due to his current role at Harley-Davidson, Inc.
03-09-2026
Albemarle Corporation announced a CEO succession plan: Ragnar Udd will become President and CEO effective February 1, 2027, succeeding Kent Masters, who will transition to Executive Chairman. Udd brings over 25 years of experience from BHP, where he served as Chief Commercial Officer. The transition is designed to ensure leadership continuity, with Masters serving as Executive Chairman through the 2027 annual meeting.
- · Udd will join the Albemarle Board of Directors upon becoming CEO.
- · Masters will serve as Executive Chairman through the 2027 annual meeting, after which his role will be reviewed as part of the Board's annual director nomination process.
- · Udd's experience includes roles as President Americas at BHP (leading copper and potash businesses), interim Chief Technology Officer, BHP Mitsubishi Asset President, and Vice President Logistics and Infrastructure for Western Australia Iron Ore.
03-09-2026
Soulpower Acquisition Corp. (SPAC) entered into a Second Amendment to its Business Combination Agreement with SWB Holdings (Pubco) and SWB LLC (Company), amending the merger consideration structure and extending the outside date to April 2, 2027. The amendment revises the merger consideration to 120% of Company Net Asset Amount plus 20% of the Uruguay Contribution Amount and $60 million for the Put Option Amount, while also requiring a minimum Company Net Asset Amount of $250 million at closing. The deal involves contributions of real estate, mineral rights, and other assets from investors, with a separate Uruguay Contribution Agreement providing for up to 111.5 million earnout shares and $5 million in cash.
- · The amendment deletes the concept of 'Additional Contribution Agreements' and replaces references with the Uruguay Contribution Agreement specifically.
- · The Uruguay Contribution Agreement involves entities Bisland SA and Los Naranjos SA in Uruguay.
- · The Merger Consideration includes a Put Option Amount of $60 million allocated solely to Carident.
- · The Outside Date for the business combination has been extended from nine months after signing (November 24, 2025) to April 2, 2027.
- · The Company Net Asset Amount definition now includes amounts paid for a BVI Banking License and under the Advisory Agreement, and excludes obligations for Uruguay Shares.
03-09-2026
Andretti Acquisition Corp. II entered into additional non-redemption agreements with new investors on September 3, 2026, to secure commitments not to redeem up to 448,959 Public Shares in exchange for up to 112,240 Pubco Shares (if a business combination closes by June 9, 2027) or up to 149,653 Pubco Shares (if closed after that date). These agreements supplement prior non-redemption agreements covering up to 5,800,000 Non-Redeemed Shares. The company is seeking shareholder approval to extend its business combination deadline from September 9, 2026 to September 9, 2027, but the non-redemption agreements are not expected to increase the likelihood of the extension being approved.
- · The non-redemption agreements are not expected to increase the likelihood that the Extension is approved by shareholders, but are expected to increase the amount of funds remaining in the trust account.
- · The Special Meeting was adjourned from August 28, 2026 to September 8, 2026 to allow more time for redemptions and reversal of redemptions.
- · The non-redemption agreements terminate upon the earliest of: failure to approve Extension, Company determination not to proceed, fulfillment of all obligations, liquidation/dissolution, mutual written agreement, or if the Investor exercises redemption rights and shares are actually redeemed.
03-09-2026
Cleartronic, Inc. (CLRI) entered into a stock repurchase agreement on August 28, 2026, to buy back 14,640,039 common shares from the Propst Family Trust for $207,500. The shares will be retired and restored to authorized but unissued status, reducing the outstanding share count. The agreement also includes a mutual release of all claims between the parties, with no admission of liability.
- · The repurchase price per share is approximately $0.0142 ($207,500 / 14,640,039 shares).
- · The shares were acquired from the Propst Family Trust, which had held various allotments over the last 15 years.
- · The agreement includes a mutual release of all known and unknown claims between the parties, with no admission of liability.
- · The shares will be cancelled and retired, not held as treasury shares, and restored to authorized but unissued status.
- · CLRI's board authorized the transaction and determined the company will remain solvent after the payment.
03-09-2026
LB Pharmaceuticals appointed Joseph Miller as CFO, effective September 3, 2026. Miller brings over 20 years of biopharmaceutical finance experience, including leading Aurinia Pharmaceuticals through its commercial launch of LUPKYNIS. The company is approaching pivotal NOVA-2 clinical trial results for lead candidate LB-102 in schizophrenia, but remains pre-revenue with no approved products and faces significant development and regulatory risks.
- · Joseph Miller previously served as CFO of Aurinia Pharmaceuticals, where he oversaw the commercial launch of LUPKYNIS, the first FDA-approved oral therapy for active lupus nephritis.
- · Miller also served as CFO, Principal Executive Officer, and Corporate Secretary of Avalo Therapeutics, leading acquisitions of Aevi Genomic Medicine and Ichorion Therapeutics and the divestiture of Avalo's commercial portfolio to Aytu BioScience.
- · Earlier roles include VP of Finance at Sucampo Pharmaceuticals (which merged with Mallinckrodt) and finance leadership at QIAGEN, Eppendorf, and KPMG LLP.
- · Miller holds a B.S. in accounting from Villanova University and is a Certified Public Accountant.
- · The company has no approved products and is pre-revenue, with all forward-looking statements subject to risks including limited operating history, historical losses, and dependence on LB-102.
03-09-2026
Medicus Pharma Ltd. entered into a Co-Development and License Agreement with Pfizer Inc. for PF-08046031 (CD228V), an early clinical-stage antibody-drug conjugate targeting melanotransferrin. The deal includes a $12.0 million upfront payment from Medicus to Pfizer, a $15.0 million payment due on the first anniversary, and a $2.0 million Development Funding Payment from Pfizer to Medicus. While the agreement provides exclusive worldwide rights and potential milestone payments exceeding $1.0 billion, it also imposes significant financial obligations on Medicus, including royalties and milestone payments to Pfizer, and the company retains sole responsibility for development costs.
- · The agreement includes tiered royalties on annual net sales at low double-digit percentages.
- · Pfizer retains ownership of licensed patent rights and has an option to fund all or part of development after the first pivotal trial.
- · Medicus must use commercially reasonable efforts to develop and commercialize in specified major market countries.
- · The agreement continues on a product-by-product and country-by-country basis until expiration of the applicable royalty term, unless earlier terminated.
03-09-2026
Alaska Silver Corp. granted 375,000 stock options to non-executive directors at C$0.71 per share for a five-year term, as part of its director compensation policy. The company also provided an update on its Illinois Creek Project in Alaska, which hosts significant silver, gold, zinc, and lead resources. No financial results or period-over-period comparisons were included in this filing.
- · The Illinois Creek Project is located 38 km from the Yukon River, the region's primary marine transportation corridor.
- · The Waterpump Creek zone remains open to the north and south.
- · The Illinois Creek Mine was a past producer that closed in 1998 and was reclaimed in 2002 due to low metal prices.
- · The company is headquartered in Alaska and Arizona.
03-09-2026
HF Foods Group Inc. completed its acquisition of Searay Foods Inc., a Canadian importer and distributor of ethnic frozen seafood, for a base purchase price of approximately CAD$47.9 million (US$35.0 million). The deal marks HF Foods' first international expansion into Canada and is expected to be immediately accretive to margins and EPS. The acquisition was funded with CAD$38.4 million in cash and 1.7 million shares of HF Foods common stock, with additional contingent consideration based on future performance.
- · Searay was founded in 2000 and is headquartered in Richmond, British Columbia.
- · Searay sources from over 80 suppliers worldwide and distributes through six proprietary brands.
- · The acquisition is expected to be immediately accretive to HF Foods' margins and EPS.
- · Searay's existing management team, led by Derick Ngan, will continue to run day-to-day operations as a subsidiary.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Material Events SEC 8-K Filings
🇺🇸 More from United States
View all →September 04, 2026
US Pre-Market SEC Filings Roundup — September 04, 2026
US Pre-Market SEC Filings Roundup
September 04, 2026
USA Corporate Events Calendar — September 04, 2026
USA Corporate Events Calendar
September 04, 2026
Global High-Priority Regulatory Events — September 04, 2026
Global High-Priority Regulatory Events
September 04, 2026
US SEC Filings Daily Market Digest — September 04, 2026
US SEC Filings Daily Market Digest